Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vets urged to back ketamine campaign
Dr Sheilah Robertson
Dr Sheilah Robertson spoke at BSAVA Congress 2016.

WSAVA concerned that access to the drug is still under threat

The WSAVA are calling on vets across the world to support its campaign to ensure continued access to ketamine for veterinary and human medicine.

Although the UN Commission of Narcotic Drugs (CND) recently rejected the international scheduling of Ketamine, the WSAVA remains concerned that access to this essential medicine is under threat.

Speaking at BSAVA Congress in Birmingham (7-10 April 2016), Dr Sheilah Robertson explained that ketamine is a safe anaesthetic which has been used worldwide for over 50 years.

“It does not depress respiration or the circulation and can be used without anaesthetics,” she said. “These characteristics make it the only anaesthetic suitable for both medical and veterinary use in the developing world.

“Ketamine also has particular value ‘in the field’ for humans and animals and is used to treat trauma, traffic and sporting injuries and those resulting from natural disasters and conflict zone,” she added.

“It is often the only product that can be used for dog and cat neutering initiatives, making it critical for the control of zoonotic diseases, such as rabies.”

Led by China, a number of countries have been campaigning to have ketamine ‘internationally rescheduled’. This would prevent access to it in most developing countries as documentation required for international scheduled drugs can be prohibitive bureaucratic.

As a result, the WSAVA say that this would put an end to surgical treatments in many parts of the world, including dog and cat neutering programmes.

But while the WHO Expert Committee on Drug Dependence (ECDD) and the UN CND have both advised against putting ketamine under international control, China has expressed its disappointment and announced that it will lobby for the decision to be revered at future meetings.

The country has a problem with the illicit production of the drug for ‘recreational’ use.

"Together with many other veterinary and medical bodies, we are strongly opposed to moves to schedule ketamine because we regard it as essential for human and veterinary medical practice and for wildlife conservation,” Dr Robertson continued.

"This is a battle our patients can't afford us to lose so we are campaigning to provide a global perspective on ketamine's importance to veterinary medicine and to unite the voices of those who support us. Our petition already has more than 5,000 signatures and we urge vets and others with an interest in this issue to show their support by signing it."

She added: "We intend to keep the debate about ketamine in the spotlight and ensure we are ready demonstrate its value when future UN meetings are proposed.

"China will, no doubt, continue to lobby for it to be internationally scheduled and we would regard this as a disastrous decision. We stand with the World Health Organisation which recently confirmed its view that ketamine is an essential medicine.”

More information about the WSAVA’s ketamine campaign is available at: www.wsava.org/educational/global-pain-council. The petition can be found at http://chn.ge/1RFSou6 

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
NSA webinar explores sheep tailing and castration

The National Sheep Association (NSA) is to host a free webinar on the castration and tail docking of lambs.

The webinar, 'Understanding the tailing and castration consultation: A guide for sheep farmers', will be hosted online on Monday, 2 March 2026 at 7.30pm.

It comes during a government consultation into the methods used for these procedures. Farmers are encouraged to engage before the consultation period closes on Monday, 9 March 2026.

The webinar offers clear and actionable guidance to support farmers to contribute meaningfully to the consultation and prepare for potential changes.

On the panel will be former SVS president Kate Hovers, farmer and vet Ann Van Eetvelt and SRUC professor in Animal Health and Veterinary Sciences Cathy Dwyer. Each panel member will utilise their own specialism and expertise to evaluate risks and outcomes to sheep farming.

Find out more about the webinar on the NSA website.